Clinical TrialsSearch results
Number of results: 856
Completed
- Pharmacokinetics, safety, and tolerability of a single-dose of SAR443765 in healthy Japanese participants
- Healthy adult participants
- Tanaka Tomoyuki
- 2023-02-28
Completed
- A Phase 1, open label study to evaluate the pharmacokinetics, safety and tolerability of single subcutaneous dose amlitelimab in healthy adult participants.
- Healthy adult participants
- Tanaka Tomoyuki
- 2022-08-31
Other
- A Randomized, Double-blind, Placebo-controlled, Single-center, Single and Multiple Oral Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral BF2.649 (pitolisant hydrochloride) in Healthy Japanese Adult Subjects
- narcolepsy
- Takuma Yonemura
- 2021-12-26
Recruiting
- A multi-centered study of feasibility in endoscopic closure using novel simple flexible device for mucosal defect after gastric endoscopic submucosal dissection
- Gastric Neoplasms
- Takizawa Kohei
- 2022-11-02
Completed
- Drug-Drug interaction study of AJM300(1) - Combination clinical pharmacology study of oral midazolam, oral prednisolone, oral atorvastatin and intravenous midazolam in healthy male subjects -
- Ulcerative Colitis
- Takeuchi Yutaka
- 2023-06-19
Completed
- Drug-Drug interaction study of AJM300 (2) - Combination clinical pharmacology study of rifampicin in healthy male subjects -
- Ulcerative Colitis
- Takeuchi Yutaka
- 2023-06-19
Recruiting
- Beamion LUNG 2: A Phase III, open-label, randomized, active-controlled, multi-centre trial evaluating orally administered BI 1810631 compared with standard of care as first-line treatment in patients with unresectable, locally advanced or metastatic non-squamous non-small cell lung cancer harbouring HER2 tyrosine kinase domain mutations
- Unresectable, locally advanced or metastatic non-squamous NSCLC harboring HER2 TKD mutations
- Takeuchi Yoshito
- 2023-12-04
Recruiting
- A Thorough QT/QTc Study of TAS-205 in Healthy Male Adult Subjects
- healthy adult males
- Takeda Shinichi
- 2024-04-11
Completed
- A phase 1 open-label study evaluating the effects of food on TAS-205 in healthy volunteers
- Duchenne Muscular Dystrophy
- Takeda Shin'ichi
- 2023-06-25
Other
- Post-marketing Clinical Trial of Pioglitazone - A Study of Preventive Effects on the Onset and Recurrence of Macrovascular Events -
- Type2 Diabetes
- Takeda Pharmaceutical Company Limited
- 2008-09-10